Package 76420-494-60

{"route": ["ORAL"], "spl_id": "ea435212-caf8-164b-e053-2a95a90a0bf6", "openfda": {"unii": ["WY6W63843K"], "rxcui": ["854880", "854894"], "spl_set_id": ["35f6c1ab-a61c-4625-b932-11a7483f1d84"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-01)", "package_ndc": "76420-494-01", "marketing_start_date": "20221005"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-30)", "package_ndc": "76420-494-30", "marketing_start_date": "20221005"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-60)", "package_ndc": "76420-494-60", "marketing_start_date": "20221005"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-90)", "package_ndc": "76420-494-90", "marketing_start_date": "20221005"}], "brand_name": "Zolpidem Tartrate", "product_id": "76420-494_ea435212-caf8-164b-e053-2a95a90a0bf6", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Agonists [MoA]", "Pyridines [CS]", "gamma-Aminobutyric Acid-ergic Agonist [EPC]"], "product_ndc": "76420-494", "dea_schedule": "CIV", "generic_name": "Zolpidem Tartrate", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zolpidem Tartrate", "active_ingredients": [{"name": "ZOLPIDEM TARTRATE", "strength": "6.25 mg/1"}], "application_number": "ANDA213592", "marketing_category": "ANDA", "marketing_start_date": "20201217", "listing_expiration_date": "20261231"}